Technical Analysis for ATXS - Astria Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 10.54 | -0.09% | -0.01 |
ATXS closed down 0.09 percent on Thursday, April 18, 2024, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -0.09% | |
| Oversold Stochastic | Weakness | -0.09% | |
| Wide Bands | Range Expansion | -5.05% | |
| Oversold Stochastic | Weakness | -5.05% | |
| Inside Day | Range Contraction | -3.21% | |
| Wide Bands | Range Expansion | -3.21% | |
| Oversold Stochastic | Weakness | -3.21% |
| Alert | Time |
|---|---|
| Up 3% | about 15 hours ago |
| 60 Minute Opening Range Breakout | about 17 hours ago |
| Up 2% | about 17 hours ago |
| Up 1% | about 17 hours ago |
| Fell Below Previous Day's Low | about 18 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Immunology Monoclonal Antibody Antibody Angioedema Hereditary Angioedema Kallikrein Complement Deficiency
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Immunology Monoclonal Antibody Antibody Angioedema Hereditary Angioedema Kallikrein Complement Deficiency
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.9 |
| 52 Week Low | 4.26 |
| Average Volume | 1,018,703 |
| 200-Day Moving Average | 8.99 |
| 50-Day Moving Average | 13.65 |
| 20-Day Moving Average | 12.38 |
| 10-Day Moving Average | 11.05 |
| Average True Range | 0.91 |
| RSI (14) | 31.97 |
| ADX | 23.1 |
| +DI | 14.36 |
| -DI | 25.84 |
| Chandelier Exit (Long, 3 ATRs) | 14.18 |
| Chandelier Exit (Short, 3 ATRs) | 13.15 |
| Upper Bollinger Bands | 15.63 |
| Lower Bollinger Band | 9.12 |
| Percent B (%b) | 0.22 |
| BandWidth | 52.56 |
| MACD Line | -0.91 |
| MACD Signal Line | -0.73 |
| MACD Histogram | -0.1819 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.21 | ||||
| Resistance 3 (R3) | 11.24 | 11.06 | 11.10 | ||
| Resistance 2 (R2) | 11.06 | 10.89 | 11.04 | 11.06 | |
| Resistance 1 (R1) | 10.80 | 10.78 | 10.93 | 10.76 | 11.02 |
| Pivot Point | 10.61 | 10.61 | 10.68 | 10.59 | 10.61 |
| Support 1 (S1) | 10.35 | 10.44 | 10.48 | 10.32 | 10.06 |
| Support 2 (S2) | 10.17 | 10.34 | 10.15 | 10.02 | |
| Support 3 (S3) | 9.91 | 10.17 | 9.98 | ||
| Support 4 (S4) | 9.87 |
